Please login to the form below
AMR Action Fund
This page shows the latest AMR Action Fund news and features for those working in and with pharma, biotech and healthcare.
Pfizer acquires Amplyx Pharmaceuticals, including new potential class of therapeutics
Last year, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) joined forces with leading pharma and biotech companies to launch the AMR Action Fund. ... In February, the AMR Action Fund raised a further $140m from new
Latest news
-
AMR Action Fund raises $140m from new investors to tackle antimicrobial resistance
The AMR Action Fund, launched last year, has raised $140m from new investors to bolster its efforts to bring new antibiotics through the clinical pipeline to patients. ... to address," said Henry Skinner, chief executive office of the AMR Action Fund.
-
Sandoz to acquire GSK’s cephalosporin antibiotic brands for up to $500m
The AMR Action Fund was created to bring two to four new antibiotics to patients by 2030 – treatments which are urgently needed to address the rapid rise of antibiotic resistance, which
-
New Oxford research institute established to tackle antimicrobial resistance
The IOI plans to partner with other global leaders in AMR research to achieve this goal. ... The AMR Action Fund was created to bring two to four new antibiotics to patients by 2030 – treatments that are urgently needed to address the rapid rise of
-
Perfect partners
Everything from developing vaccines in months rather than years, CEOs’ partnering in open letters reaffirming safety before speed, 20 biopharmaceutical companies creating the AMR Action Fund to bring new antibiotics to
-
MSD launches antibiotic combo Recarbrio in UK
The aptly named AMR Action Fund is aiming to bring two to four new antibiotics to patients by 2030. ... Current reimbursement frameworks simply do not support the level of sustained R&D investment that is needed to tackle AMR.
More from news
Approximately 2 fully matching, plus 6 partially matching documents found.
Latest Intelligence
-
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
However, the AMR Action Fund is not the permanent solution to the AMR threat. ... But the pipeline is on the verge of collapse and the AMR Action Fund is only a partial solution.
More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.
Latest appointments
-
Henry Skinner has been appointed as the first CEO of the AMR Action Fund
I am honoured to join the AMR Action Fund and its incredibly important mission. ... I am proud and excited to lead the AMR Action Fund in its efforts to tackle the global challenge of AMR.
More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
B2B media account director
-
Competitive salary
- Scientific Director, MRNA/ Covid 19, Medical Communications, UK
-
Six figure salary
- Senior Account Exec > CSD – Medical Communications – UK, Lond...
-
Highly Competitive Salary, Bonus &Benefits
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Principal Medical Writer, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Account Supervisor – Leading Healthcare Advertising Agency – New...
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writers > Scientific Directors – Medical Communicatio...
-
Highly Competitive Salary, Bonus &Benefits
- Vaccines writer – career opportunity to move into medcomms from ...
-
Highly competitive salary
- Senior Medical Writer – Creative Healthcare Advertising – New Yo...
-
Highly Competitive Salary, Bonus &Benefits
- First trial of a vaccine against Alzheimer’s launches
- Gilead’s Trodelvy approved for triple-negative breast cancer in Europe
- US government to pay $5.3bn for Pfizer‘s Paxlovid
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Roche to present new data for its drug Polivy at the American Society of Hematology’s annual meeting
- bluebird bio’s beti-cel accepted for priority review by FDA
- As HCPs Increasingly Expect Personalized Engagement, Pharmas Turn to Modular Intelligent Content. How Does This Work?
- COVID-19 vaccines against Omicron may be fast-tracked
- BMS’ new JAK inhibitor enters regulatory pathways
- Onyx Health Announces Two Top Appointments
- Omicron prompts global action
- Novo Nordisk growth takes a hit with China deal
- Results for Merck’s oral cholesterol inhibitor show it to be ‘highly effective’
- Six ways to improve diversity in clinical trials
- Innovation in a digital context is not about technology – it’s about people
- Gilead’s Trodelvy approved for triple-negative breast cancer in Europe
- Novartis forms coronavirus alliance with life sciences companies
- Pfizer lifts 2021 guidance as sales of its BioNTech-partnered vaccine continue to climb
PMHub
TRIDUCIVE
Triducive are a strategic healthcare consultancy who produce communications that have practical, dynamic application that encourage behaviour change because of the...
Latest intelligence
- Webinar:
- Securing a future for telehealth with immersive market research insights...
- Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
- How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
- Six ways to improve diversity in clinical trials
- Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...
